These results support case-control reports revealing a correlation between advanced tumor staging and hnRNPK cytoplasmic localization, and provide a mechanism that defines the robust, Fbxo4-dose dependent, metastatic spread in Fbxo4 knock-out mice that express the BrafV600E oncogene in melanocytes17. The gene discussed is HNRNPK; the disease is neoplasm.